Free shipping on all orders over $ 500

Apatinib mesylate

Cat. No. M1956

All AbMole products are for research use only, cannot be used for human consumption.

Apatinib mesylate Structure

Rivoceranib mesylate; YN968D1

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
5mg USD 120  USD120 In stock
10mg USD 180  USD180 In stock
50mg USD 540  USD540 In stock
100mg USD 840  USD840 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Apatinib (also known as YN968D1) is an orally bioavailable, small molecule inhibitor that selectively inhibits the vascular endothelial growth factor receptor-2 (VEGFR2, also known as KDR). Apatinib specifically inhibits VEGF-mediated endothelial cell migration and proliferation thus blocking new blood vessel formation in tumor tissue. Apatinib also mildly inhibits c-Kit and c-SRC tyrosine kinases. Apatinib (YN968D1) significantly enhanced the cytotoxicity of ABCB1 or ABCG2 substrate drugs in KBv200, MCF-7/adr, and HEK293/ABCB1 cells overexpressing ABCB1 and in S1-M1-80, MCF-7/FLV1000, and HEK293/ABCG2-R2 cells overexpressing ABCG2 (wild-type). Apatinib significantly increased the intracellular accumulation of rhodamine 123 and doxorubicin in the multidrug resistance (MDR) cells. Furthermore, apatinib (YN968D1) significantly increased the ATPase activity of both ABCB1 and ABCG2.

Product Citations
Customer Product Validations & Biological Datas
Source Cell Cycle (2018 Jul). Figure 4. Apatinib (Abmole Bioscience)
Method cellular proliferation assay
Cell Lines SiHa cells
Concentrations 20 μM
Incubation Time 24 hour
Results In addition, Gene Ontology analysis showed that the genes involved in mitotic cell cycle (both G1/S transition and G2/M transition), cell division, DNA repair, and cell proliferation were under the precise regulation of Apatinib
Source Cell Cycle (2018 Jul). Figure 3. Apatinib (Abmole Bioscience)
Method cellular proliferation assay
Cell Lines SiHa and Hcc94 cells
Concentrations 10 μM and 20 μM
Incubation Time 24 hour
Results Then we detected the effects of Apatinib on cellular mitochondrial membrane potential (an apoptotic marker).
Source Cell Cycle (2018 Jul). Figure 2. Apatinib (Abmole Bioscience)
Method cellular proliferation assay
Cell Lines C33A and HeLa cells
Concentrations 10 μM and 20 μM
Incubation Time 24 hour
Results Further, the 24-hour treatment of Apatinib induced significant G1-phase arrest in a dose-dependent manner in both SiHa and Hcc94 cells
Protocol (for reference only)
Cell Experiment
Cell lines HUVEC cells
Preparation method Cell proliferation assays.
The HUVEC were seeded into 96-well plates. After 24 h of incubation, cells were exposed to the test agents (vehicle as control) together with 20 ng⁄ mL VEGF or 20% FBS for another 72 h. After fixation with 10% trichloroacetic acid, the cells were stained with 0.4% sulforhodamine B for 30 min at 37C and then washed with 1% acetic acid. Tris was added to dissolve the complex, and the optical density was measured at 520 nm.
Concentrations 0.1 and 1μM
Incubation time 72 h
Animal Experiment
Animal models Ls174t, HCT 116, SGC-7901, HT-29, A549, NCI-H460 cells tumour xenograft in BALB/cA nude mice
Formulation 0.5% (w ⁄ v) carboxymethyl cellulose and 5% (w ⁄ v) glucose solution
Dosages 50, 100, 200 mg/kg once daily for 14, 18 or 21days
Administration oral gavage
Chemical Information
Molecular Weight 493.58
Formula C25H27N5O4S
CAS Number 1218779-75-9
Solubility (25°C) DMSO 22 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month

[1] Tong XZ, et al. Biochem Pharmacol. Apatinib (YN968D1) enhances the efficacy of conventional chemotherapeutical drugs in side population cells and ABCB1-overexpressing leukemia cells.

[2] Tian S, et al. Cancer Sci. YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo.

[3] Mi YJ, et al. Cancer Res. Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters.

Related VEGFR/PDGFR Products

Isolinderalactone suppresses human glioblastoma growth and angiogenic activity through the inhibition of VEGFR2 activation in endothelial cells. Isolinderalactone suppressed the expression of B-cell lymphoma 2 (BCL-2), as well as of survivin and X-linked inhibitor of apoptosis protein (XIAP).


Oglufanide (H-Glu-Trp-OH) is a dipeptide immunomodulator isolated from calf thymus.


KLTWQELYQLKYKGI (QK) is a VEGF mimicking peptide, binds to the VEGF receptors and competes with VEGF.

Protein LMWP

Protein LMWP is a cell-penetrating peptide with vascular endothelial growth factor (VEGF) inhibitory activity.


CBO-P11 specifically binds to receptor of VEGFR-2 and is used as targeting ligand for tumor angiogenesis.

Abmole Inhibitor Catalog

Keywords: Apatinib mesylate, Rivoceranib mesylate; YN968D1 supplier, VEGFR/PDGFR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.